Cumberland Pharmaceuticals Inc. (CPIX) Reaches New 52-Week High at $7.66

Cumberland Pharmaceuticals Inc. (NASDAQ:CPIX)’s share price hit a new 52-week high on Thursday . The stock traded as high as $7.66 and last traded at $0.00, with a volume of shares trading hands.

Cumberland Pharmaceuticals (NASDAQ:CPIX) last posted its quarterly earnings results on Tuesday, August 8th. The specialty pharmaceutical company reported ($0.07) earnings per share (EPS) for the quarter. The firm had revenue of $8.67 million for the quarter. Cumberland Pharmaceuticals had a negative return on equity of 0.13% and a negative net margin of 19.57%.

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Ameriprise Financial Inc. raised its holdings in Cumberland Pharmaceuticals by 0.3% during the second quarter. Ameriprise Financial Inc. now owns 23,892 shares of the specialty pharmaceutical company’s stock worth $167,000 after purchasing an additional 80 shares in the last quarter. Vanguard Group Inc. raised its holdings in Cumberland Pharmaceuticals by 0.4% during the second quarter. Vanguard Group Inc. now owns 298,635 shares of the specialty pharmaceutical company’s stock worth $2,111,000 after purchasing an additional 1,180 shares in the last quarter. Dimensional Fund Advisors LP raised its holdings in Cumberland Pharmaceuticals by 0.3% during the second quarter. Dimensional Fund Advisors LP now owns 866,283 shares of the specialty pharmaceutical company’s stock worth $6,125,000 after purchasing an additional 2,464 shares in the last quarter. Essex Investment Management Co. LLC raised its holdings in Cumberland Pharmaceuticals by 45.8% during the second quarter. Essex Investment Management Co. LLC now owns 15,959 shares of the specialty pharmaceutical company’s stock worth $112,000 after purchasing an additional 5,014 shares in the last quarter. Finally, Renaissance Technologies LLC raised its holdings in Cumberland Pharmaceuticals by 5.2% during the first quarter. Renaissance Technologies LLC now owns 270,240 shares of the specialty pharmaceutical company’s stock worth $1,875,000 after purchasing an additional 13,240 shares in the last quarter. 34.29% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY NOTICE: “Cumberland Pharmaceuticals Inc. (CPIX) Reaches New 52-Week High at $7.66” was first posted by Community Financial News and is the property of of Community Financial News. If you are viewing this report on another publication, it was stolen and reposted in violation of international trademark & copyright law. The correct version of this report can be read at https://www.com-unik.info/2017/11/02/cumberland-pharmaceuticals-inc-cpix-reaches-new-52-week-high-at-7-66.html.

Cumberland Pharmaceuticals Company Profile

Cumberland Pharmaceuticals Inc (Cumberland) is a specialty pharmaceutical company. The Company is focused on the acquisition, development and commercialization of branded prescription products. The Company operates through specialty pharmaceutical products segment. The Company’s product portfolio includes Acetadote (acetylcysteine) Injection for the treatment of acetaminophen poisoning; Caldolor (ibuprofen) Injection for the treatment of pain and fever; Kristalose (lactulose) for Oral Solution for the treatment of chronic and acute constipation; Omeclamox-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori (H.

What are top analysts saying about Cumberland Pharmaceuticals Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Cumberland Pharmaceuticals Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit